Under the agreement, Think Surgical will have exclusive distribution rights to Curexo’s Cuvis-Joint robotic platform, according to an Aug. 1 news release. The companies have a history distributing Think Surgical’s TSolution One platform in Korea and Vietnam.
The Cuvis-Joint robot is used in Korea and India, with more than 4,000 cases done with the device. Think Surgical will be responsible for getting Cuvis-Joint FDA-cleared in the U.S.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
